Influenza and COVID-19 Vaccine Concerns and Uptake Among Patients Cared for in a Safety-Net Health System

Author:

Davis Terry C.1ORCID,Vanchiere John A.1,Sewell Michael R.1,Davis Adrienne B.1,Wolf Michael S.2,Arnold Connie L.1

Affiliation:

1. Louisiana State University Health Shreveport, Shreveport, LA, USA

2. Feinberg School of Medicine, Evanston, IL, USA

Abstract

Objectives: To examine Influenza and COVID-19 vaccine concerns and uptake among adult patients in a Southern safety-net health system. Methods: Trained research assistants conducted a structured telephone interview from April to October 2021. Of 118 participants, mean age was 57.7 years, 63.6% were female, 55.1% were Black, 42.4% white, and 54.2% reported rural residence. Results: Among participants, 44.9% had received the influenza vaccine during the 2020 to 2021 season, and 66.1% had received the COVID-19 vaccine. Participants who received the influenza vaccine were more likely to report getting a COVID-19 vaccine compared to those who reported not getting a flu vaccine (81.1% vs 53.8%, P = .002). Black adults were significantly less likely than white adults (29.2% vs 46.0%, P = .048) and bordering on significance, males less likely than females (27.9% vs 41.3%, P = .054) to have reported receiving both vaccines. Of note, 25.4% of participants did not get either vaccine. The most common reasons for not getting the influenza vaccine were not being concerned about getting the flu (13.8%) and belief the vaccine gave them the flu (12.3%). The primary reasons for not getting a COVID-19 vaccine were concern about vaccine safety (22.5%), concern about side effects (20.0%), and belief they were not going to get sick (20.0%). Conclusions: These findings could help direct regional vaccine messaging and clinical communication to improve vaccine uptake among underserved populations.

Funder

National Institute of General Medical Sciences

Publisher

SAGE Publications

Subject

Public Health, Environmental and Occupational Health,Community and Home Care

Reference39 articles.

1. The Dual Epidemics of COVID-19 and Influenza

2. Centers for Disease Control and Prevention. COVID data tracker. 2022. Accessed September 2, 2022. https://covid.cdc.gov/covid-data-tracker/#datatracker-home

3. Centers for Disease Control and Prevention. Disease burden of flu. 2022. Accessed September 2, 2022. https://www.cdc.gov/flu/about/burden/index.html

4. Centers for Disease Control and Prevention. COVID-19 vaccines continue to protect against hospitalization and death among adults. 2022. Accessed May 5, 2022. https://www.cdc.gov/media/releases/2022/s0318-COVID-19-vaccines-protect.html#:~:text=COVID%2D19%20vaccines%20continue%20to%20protect%20against%20hospitalization%20and%20death%20among%20adults,Media%20Statement&text=COVID%2D19%20vaccination%20continues%20to,reports%20released%20in%20today’s%20MMWR

5. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3